Sperm Function Testing Market By Product Type (Andro Scope-Basic, Andro Scope-Advanced, and Others), By Test Type(Sperm function Test, Sperm-mucus Interaction Tests, and Others), By End User(Hospitals, Sperm Labs, and Others), and by Region and Companies Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2022-2032.

Sperm Function Testing Market Overview:

The Sperm Function Testing Market is projected to reach a valuation of USD 2.59 Bn by 2032 at a CAGR of 5.3%, from USD 1.9 Bn in 2021.

In order to ensure that a couple is able to conceive, a variety of tests are often performed on both the man and woman. One such test that is conducted on a man is the sperm function test. This type of test is used to evaluate the ability of the sperm to move and swim properly, as well as their ability to penetrate an egg.

The test can determine whether or not the sperm are able to move properly, are abnormally shaped, or have low levels of motility. The test can also help to identify any potential causes of infertility in men. If abnormalities are found in the sperm, steps can be taken to correct them in order to increase the likelihood of conception.

Many people believe that sperm function testing is now irrelevant due to advances in in-vitro fertilization (IVF) technology, especially the Intracytoplasmic Sperm Injection (ICSI) technique. ICSI has definitely given hope to couples who previously had virtually no chance of conception with their own gametes. Many couples without severe sperm defects can be treated using less invasive and expensive options provided better sperm function tests to ensure normal fertilization without the use of ICSI.

The various types of sperm function tests include vitality tests, sperm-mucus interaction tests, capacitation, acrosome reaction, zona binding assays, and hamster ovum penetration test.

Detailed Segmentation

Based on Product Type:

• Andro Scope-Basic
• Andro Scope-Advanced
• Sperm Counting Chamber
• Collection Room Device
• Androbox
• Micro CO2 Incubator
• Slide Warmer
• Aqua Warmer
• Micropipettes

Based on Test Type:

• Sperm function Test
• Sperm-mucus Interaction Tests
• Capacitation
• Acrosome Reaction
• Zona Binding Assays
• Sperm DNA Fragmentation
• Vitality Tests
• Hamster Ovum Penetration Test

Based on End User:

• Hospitals
• Sperm Labs
• Clinical Laboratory
• Online Pharmacy
• Retail Pharmacy

Based on Region:

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Market Dynamics

Driver:

Infertility has been cited as a major factor fueling the growth of the sperm function testing market, with abnormal sperm functioning, sperm delivery problems, overexposure to certain environmental factors such as pesticides and other chemicals, radiation, cigarette smoking, and heavy alcohol consumption are all elements contributing to the revenue growth of this market.

According to Human Reproduction (Oxford, England), the prevalence of infertility was 12.5% (CI 95% 11.7–13.3) among women and 10.1% (CI 95% 9.2–11.1) among men. Increased prevalence was associated with later cohabitation with a partner, higher socioeconomic status, and, for those who had a child, becoming parents at an older age.

Restraint:

The significant expense of these procedures may be a particular reason for the lack of adoption in developing business sectors, in turn hampering the development of the sperm function testing market. Nonetheless, high evaluation of these new testing procedures raises the issue of functionality, whose cutoff points to market development, particularly in these areas.

Additionally, high testing costs may hamper this target market’s revenue growth. The fear of visiting a diagnostic center due to the COVID 19 pandemic is another restraining factor that is presently being observed.

Competitive Landscape

• Medical Electronic System
• Hamilton Thorne Inc.
• Microptic S.L.
• CooperSurgical Inc.
• Proiser
• Sperm Processor Pvt. Ltd.
• Bioline Technologies (India)
• ContraVac Inc.
• MotilityCount Aps
• MMC Soft
• MedSystems International LLC.
• LabIVF Asia Pte. Ltd.
• Stormoff
• Mira Lab
• Beijing Weili New Century Science & Tech.

Recent Development:

• In July 2020, Bonraybio Co. Ltd. Got US FDA endorsement LensHooke X1 PRO Semen Quality Analyzer: Several organizations have been seen to lift their creation volume with the agreement arrangement.
• For Instance, the Bonraybio Co. Ltd., The LensHooke X1 PRO Semen Quality Analyzer doesn’t give an extensive, assessment of a male’s richness status. It is an in-vitro analytic framework proposed for human semen examination of people in medical care proficient settings to assess male fertility.

For the XXXXX Market research study, the following years have been considered to estimate the market size: